FRA:G93 (China)
Â
Class H
€
0.80
+0.015 (+1.91%)
Apr 7
Warning! GuruFocus detected
3 Severe warning signs
with G93.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Jiangsu Recbio Technology Co Ltd
ISIN : CNE1000057K9
Share Class Description:
FRA:G93: Class HCompare
Compare
Traded in other countries / regions
02179.Hong KongG93.Germany IPO Date
2024-07-25Description
Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.76 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.83 | |||||
| Debt-to-EBITDA | -1.31 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -58.4 | |||||
| 3-Year EPS without NRI Growth Rate | -41 | |||||
| 3-Year FCF Growth Rate | -48.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 75.76 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.9 | |||||
| 9-Day RSI | 37.12 | |||||
| 14-Day RSI | 36.67 | |||||
| 3-1 Month Momentum % | -9.35 | |||||
| 6-1 Month Momentum % | -4.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.17 | |||||
| Quick Ratio | 0.96 | |||||
| Cash Ratio | 0.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | -8.07 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -50.06 | |||||
| ROA % | -25.3 | |||||
| ROIC % | -43.04 | |||||
| 3-Year ROIIC % | -63.48 | |||||
| ROC (Joel Greenblatt) % | -57.6 | |||||
| ROCE % | -31.28 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.77 | |||||
| Price-to-Tangible-Book | 4 | |||||
| EV-to-EBIT | -6.24 | |||||
| EV-to-EBITDA | -6.24 | |||||
| EV-to-FCF | -4.39 | |||||
| Earnings Yield (Greenblatt) % | -16.04 | |||||
| FCF Yield % | -23.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jiangsu Recbio Technology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.153 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 36.67 | ||
| 14-Day ATR (€) | 0.031377 | ||
| 20-Day SMA (€) | 0.86425 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.77 - 1.15 | ||
| Shares Outstanding (Mil) | 482.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jiangsu Recbio Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jiangsu Recbio Technology Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jiangsu Recbio Technology Co Ltd Frequently Asked Questions
What is Jiangsu Recbio Technology Co Ltd(FRA:G93)'s stock price today?
The current price of FRA:G93 is €0.80. The 52 week high of FRA:G93 is €1.15 and 52 week low is €0.77.
When is next earnings date of Jiangsu Recbio Technology Co Ltd(FRA:G93)?
The next earnings date of Jiangsu Recbio Technology Co Ltd(FRA:G93) is .
Does Jiangsu Recbio Technology Co Ltd(FRA:G93) pay dividends? If so, how much?
Jiangsu Recbio Technology Co Ltd(FRA:G93) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers